![](/img/cover-not-exists.png)
Erythropoiesis-Stimulating Agent Use Among Non–Dialysis-Dependent CKD Patients Before and After the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Using a Large US Health Plan Database
Thamer, Mae, Zhang, Yi, Kshirsagar, Onkar, Cotter, Dennis J., Kaufman, James S.Volume:
64
Language:
english
Journal:
American Journal of Kidney Diseases
DOI:
10.1053/j.ajkd.2014.05.013
Date:
November, 2014
File:
PDF, 933 KB
english, 2014